caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1952310500

Martha ArellanoMD

Hematology-OncologyAtlanta, GAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Martha Arellano's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 19 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
CRAWFORD LONG HOSPITAL131977
John Roback
Pathology · Atlanta, GA
88793
Kyle Bradley
Pathology · Atlanta, GA
2893
Shiyong Li
Pathology · Atlanta, GA
26125
Linsheng Zhang
Pathology · Charleston, SC
2496
Amelia Langston
Medical Oncology · Atlanta, GA
1897
Paul Johnson
Nurse Practitioner · Atlanta, GA
1871
Geoffrey Smith
Pathology · Atlanta, GA
1733
Carmen Hancock
Nurse Practitioner · Greenville, SC
15101
Zaid Al-Kadhimi
Hematology-Oncology · Omaha, NE
1561
Gerard Mcgorisk
Internal Medicine · Atlanta, GA
1441
Sagar Lonial
Hematology-Oncology · Atlanta, GA
1335
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
140
Unique beneficiaries
—
Total services
288
Distinct HCPCS
6
Medicare payment
$20K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 236 Hematology-Oncology providers in GA — bottom quintile (cohort median 1,046).
PRESCRIBING · PART D · 2024
Total Rx claims
296
Beneficiaries
—
Total drug cost
$2.5M
Distinct drugs
14
Brand share
60.5%
Top prescribed drugs
Valacyclovir Hcl46 claims
Imatinib Mesylate43 claims
Ivosidenib37 claims
Dasatinib27 claims
Ponatinib Hcl19 claims
QUALITY · MIPS · 2024
Final MIPS score
94.5
Quality
80.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.82%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$103
Payment records
2
By payment type
Food and Beverage$103